BWXT Names Robb A. LeMasters as Next Chief Financial Officer
Current CFO David Black to Retire After 30 Years at BWXT and Serve as Special Advisor to CEO.
OPG awards contract for complex parts for nuclear refurbishment
Peterborough – Ontario Power Generation (OPG) and BWX Technologies, Inc. (NYSE: BWXT) are announcing a contract for Fuelling Machine (FM) head engineering and component supply as part of refurbishment of the Darlington Nuclear Generating Station.
BWX Technologies Reports Third Quarter 2021 Results, Narrows 2021 Guidance and Strategically Deploys Capital to Repurchase Shares
BWXT Awarded $21 Billion Environmental Management Contract for DOE’s Savannah River Site
(LYNCHBURG, Va. – Oct. 28, 2021) – BWX Technologies, Inc. (NYSE: BWXT) today announced a contract with an estimated ceiling of approximately $21 billion over a 10-year ordering period from the U.S. Department of Energy (DOE) for environmental management operations at the Savannah River Site (SRS) in South Carolina.
BWXT Medical and Bayer AG Enter into Agreement for the Development and Production of Actinium-225
(OTTAWA, Ontario – September 16, 2021) – BWX Technologies, Inc. (NYSE: BWXT) announced today that its BWXT Medical Ltd. subsidiary (BWXT Medical) has entered into an agreement with Bayer AG (Bayer) to develop Actinium-225 (Ac-225) supply and further partnering opportunities on finished products as both companies broaden their respective commercialization strategies for targeted radionuclide therapies (TRTs) and other innovative products.
BWXT Awarded CA$40 Million Contract to Supply Heat Exchangers for Bruce Power
BWX Technologies, Inc. (NYSE: BWXT) today announced a contract from Bruce Power valued at approximately CA$40 million to supply four moderator heat exchangers.
BWX Technologies Reports Second Quarter 2021 Results and Continues Progress On Future Growth Milestones
BWXT Medical Enters into a New Long-Term Agreement with Boston Scientific
(Ottawa, Ontario – May 10, 2021) – BWXT Medical Ltd. (BWXT Medical) announced today that it has entered into a new long-term, mutually exclusive agreement to manufacture TheraSphere™ Y-90 Glass Microspheres for Boston Scientific, a leading global medical device company.
BWX Technologies Reports First Quarter 2021 Results and Commences New Multi-Year Guidance Framework
BWXT Expands Technical Fellows Program
(LYNCHBURG, Va. – April 27, 2021) – BWX Technologies, Inc. (NYSE: BWXT) has expanded its existing technical fellows initiative by selecting 25 additional employees for the program in recognition of their scientific and engineering accomplishments at the company.